Using Values to Enhance Inmates' Response to Substance Use and HIV Risk Feedback
NCT ID: NCT03501732
Last Updated: 2019-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2019-08-27
2020-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators propose to develop, fine-tune, and pilot-test a computerized system for risk assessment and feedback, including evaluation of a brief pre-feedback prosocial values affirmation exercise (Cohen \& Sherman, 2014) aimed at decreasing defensiveness and increasing inmates' willingness to access and process risk-relevant information and to utilize post-release treatment resources, thereby reducing post-release substance misuse, HIV risk behavior, and criminal recidivism. Participants will be 170 jail inmates nearing release into the community - 20 pilot participants and 150 study participants randomly assigned to one of three conditions: (1) Values Affirmation + Personalized Risk Feedback; (2) Personalized Risk Feedback only; (3) Control. The baseline and risk assessment, values affirmation manipulation, and personalized risk feedback will be presented via touch-screen computers, requiring minimal training to administer. Analyses will assess:
1. The feasibility of utilizing a computerized system to assess and share risk information with jail inmates, including a brief values affirmation exercise to reduce defensiveness;
2. The acceptability of this approach from the perspectives of jail staff and inmates themselves;
3. The impact of the intervention on observed proximal outcomes (mechanisms of action), such as time spent viewing feedback, electing to print a copy of informational and treatment resources, and consequent changes in perceptions of risk, treatability, etc.;
4. The impact of the intervention on key post-release outcomes including engagement in relevant treatment services, substance misuse, HIV risk behaviors, re-offense and re-arrest;
5. The links between proximal outcomes (MOAs) and key post-release outcomes;
6. Potential moderators of treatment effectiveness.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Jail-Based Impact of Crime Intervention
NCT01378936
Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users
NCT01741350
Evaluation of Re-Entry Values and Mindfulness Program (REVAMP) With Jail Inmates
NCT01378923
Monitoring and Feedback in Substance Abuse Treatment
NCT01465490
Testing the Effectiveness of a Graphic Novel Health Education Curriculum for Patients With Addiction
NCT02378181
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Values Affirmation plus Risk Feedback
Values Affirmation with Risk Feedback in substance use and HIV domains of risk
Values Affirmation
Experimental Group selects two values and describes why they are important
Risk Feedback
Experimental and comparator conditions both receive normative feedback in domains of risk
Risk Feedback
Sham Values Affirmation with Risk Feedback in substance use and HIV domains of risk
Risk Feedback
Experimental and comparator conditions both receive normative feedback in domains of risk
Sleep Control
Description of sleep habits in lieu of values affirmation/sham values affirmation. No risk feedback
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Values Affirmation
Experimental Group selects two values and describes why they are important
Risk Feedback
Experimental and comparator conditions both receive normative feedback in domains of risk
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* post-sentencing with a sentence (i.e., less than 12 months) likely to be served out at the jail (vs. a state or federal prison) and likely to be released into the community. The invitation to participate will be timed so treatment is delivered toward the end of incarceration (within one week of release) to minimize decay of effects, and to capitalize on the motivational value of the up-coming release.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
OAR, Fairfax
UNKNOWN
Slonky, Inc
UNKNOWN
George Mason University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
June Tangney
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
June P Tangney, PhD
Role: PRINCIPAL_INVESTIGATOR
George Mason University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.